{"quoteSummary":{"result":[{"defaultKeyStatistics":{"maxAge":1,"priceHint":{"raw":2,"fmt":"2","longFmt":"2"},"enterpriseValue":{"raw":49979990016,"fmt":"49.98B","longFmt":"49,979,990,016"},"forwardPE":{"raw":17.114286,"fmt":"17.11"},"profitMargins":{"raw":0.18595,"fmt":"18.59%"},"floatShares":{"raw":51662289,"fmt":"51.66M","longFmt":"51,662,289"},"sharesOutstanding":{"raw":177832992,"fmt":"177.83M","longFmt":"177,832,992"},"sharesShort":{},"sharesShortPriorMonth":{},"heldPercentInsiders":{},"heldPercentInstitutions":{},"shortRatio":{},"shortPercentOfFloat":{},"beta":{"raw":-0.265456,"fmt":"-0.27"},"morningStarOverallRating":{},"morningStarRiskRating":{},"category":null,"bookValue":{"raw":71.426,"fmt":"71.43"},"priceToBook":{"raw":3.3545208,"fmt":"3.35"},"annualReportExpenseRatio":{},"ytdReturn":{},"beta3Year":{},"totalAssets":{},"yield":{},"fundFamily":null,"fundInceptionDate":{},"legalType":null,"threeYearAverageReturn":{},"fiveYearAverageReturn":{},"priceToSalesTrailing12Months":{},"lastFiscalYearEnd":{"raw":1490918400,"fmt":"2017-03-31"},"nextFiscalYearEnd":{"raw":1553990400,"fmt":"2019-03-31"},"mostRecentQuarter":{},"earningsQuarterlyGrowth":{},"revenueQuarterlyGrowth":{},"netIncomeToCommon":{"raw":1885319936,"fmt":"1.89B","longFmt":"1,885,319,936"},"trailingEps":{"raw":10.6,"fmt":"10.60"},"forwardEps":{"raw":14.0,"fmt":"14"},"pegRatio":{"raw":1.37,"fmt":"1.37"},"lastSplitFactor":null,"lastSplitDate":{},"enterpriseToRevenue":{"raw":4.93,"fmt":"4.93"},"enterpriseToEbitda":{"raw":20.642,"fmt":"20.64"},"52WeekChange":{"raw":0.28510404,"fmt":"28.51%"},"SandP52WeekChange":{"raw":0.12668931,"fmt":"12.67%"},"lastDividendValue":{},"lastCapGain":{},"annualHoldingsTurnover":{}},"earnings":{"maxAge":86400,"earningsChart":{"quarterly":[{"date":"1Q2016","actual":{"raw":2.15,"fmt":"2.15"},"estimate":{"raw":1.99,"fmt":"1.99"}},{"date":"2Q2017","actual":{"raw":1.65,"fmt":"1.65"},"estimate":{"raw":3.04,"fmt":"3.04"}}],"currentQuarterEstimateDate":"3Q","currentQuarterEstimateYear":2017},"financialsChart":{"yearly":[{"date":2014,"revenue":{"raw":8458536000,"fmt":"8.46B","longFmt":"8,458,536,000"},"earnings":{"raw":1353184000,"fmt":"1.35B","longFmt":"1,353,184,000"}},{"date":2015,"revenue":{"raw":8893120000,"fmt":"8.89B","longFmt":"8,893,120,000"},"earnings":{"raw":1481454000,"fmt":"1.48B","longFmt":"1,481,454,000"}},{"date":2016,"revenue":{"raw":9943217000,"fmt":"9.94B","longFmt":"9,943,217,000"},"earnings":{"raw":1686717000,"fmt":"1.69B","longFmt":"1,686,717,000"}},{"date":2017,"revenue":{"raw":10138662000,"fmt":"10.14B","longFmt":"10,138,662,000"},"earnings":{"raw":1885320000,"fmt":"1.89B","longFmt":"1,885,320,000"}}],"quarterly":[]},"financialCurrency":"INR"},"summaryProfile":{"address1":"142-48, Swami Vivekananda Road","address2":"Jogeshwari (West)","city":"Mumbai","zip":"400102","country":"India","phone":"91 22 3071 9100","fax":"91 22 2678 8123","website":"http://www.fdcindia.com","industry":"Drug Manufacturers - Major","sector":"Healthcare","longBusinessSummary":"FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the MMO3, Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides a range of active pharmaceutical ingredients. The company was founded in 1936 and is headquartered in Mumbai, India.","companyOfficers":[],"maxAge":86400},"financialData":{"maxAge":86400,"currentPrice":{"raw":239.6,"fmt":"239.60"},"targetHighPrice":{"raw":280.0,"fmt":"280.00"},"targetLowPrice":{"raw":280.0,"fmt":"280.00"},"targetMeanPrice":{"raw":280.0,"fmt":"280.00"},"targetMedianPrice":{"raw":280.0,"fmt":"280.00"},"recommendationMean":{"raw":2.0,"fmt":"2.00"},"recommendationKey":"buy","numberOfAnalystOpinions":{"raw":1,"fmt":"1","longFmt":"1"},"totalCash":{},"totalCashPerShare":{},"ebitda":{"raw":2421306880,"fmt":"2.42B","longFmt":"2,421,306,880"},"totalDebt":{},"quickRatio":{"raw":3.211,"fmt":"3.21"},"currentRatio":{"raw":4.199,"fmt":"4.20"},"totalRevenue":{"raw":10138661888,"fmt":"10.14B","longFmt":"10,138,661,888"},"debtToEquity":{},"revenuePerShare":{"raw":57.012,"fmt":"57.01"},"returnOnAssets":{"raw":0.095869996,"fmt":"9.59%"},"returnOnEquity":{"raw":0.16027,"fmt":"16.03%"},"grossProfits":{"raw":6565136000,"fmt":"6.57B","longFmt":"6,565,136,000"},"freeCashflow":{"raw":1214502144,"fmt":"1.21B","longFmt":"1,214,502,144"},"operatingCashflow":{"raw":1533223040,"fmt":"1.53B","longFmt":"1,533,223,040"},"earningsGrowth":{},"revenueGrowth":{},"grossMargins":{"raw":0.64752996,"fmt":"64.75%"},"ebitdaMargins":{"raw":0.23882,"fmt":"23.88%"},"operatingMargins":{"raw":0.20599002,"fmt":"20.60%"},"profitMargins":{"raw":0.18595,"fmt":"18.59%"},"financialCurrency":"INR"}}],"error":null}}